Senior managers from the health sector from Abu Dhabi will participate for the first time in the Biomed Israel conference

Biomed Israel 2023, Israel's leading international life sciences and health technologies conference, which will be held next week between May 18-16 at the David Intercontinental Tel Aviv Hotel, will for the first time host a delegation of senior managers from Abu Dhabi, Dubai and Casablanca.

Thousands of guests are expected to participate in the conference, including senior managers of companies, scientists, doctors, investors and among them over 1,000 guests from abroad from more than 45 countries. Similar to previous years, hundreds of Israeli companies from the field of life sciences, including over 100 start-ups , will present the innovative solutions and technologies they have developed.

At the conference, there will be several events with the participation of senior health experts who will come from the partner countries of the Abraham Accords. Among them, a plenary lecture with the director of the Dubai Science Park and a presentation by the CEO of the Abu Dhabi Stem Cell Center that will be presented as part of the academic commercialization session. The delegation will devote a significant part of its visit to building relationships and strategic collaborations with colleagues from the Israeli life sciences industry.

Susan. Kay. Feinston, Senior Advisor, Princeton Capital Advisors, who played a central role in organizing the visit: "Biomed Israel, as the leading life sciences event in the Middle East and North Africa, is an exceptional opportunity for companies and organizations in the life sciences from the partner countries of the Abraham Accords to find partnerships that will expand access to life-saving drugs and provide patients Innovative medical technologies".

Feinstone added: "The Abraham Accords partnership already maintains collaborations with organizations in Israel for the benefit of patients throughout the region. Among other things, Sheba Medical Center has already broken ground with the establishment of a state-of-the-art hospital of its kind in Manama, the capital of Bahrain, and Teva is collaborating with Cooper Pharma from Morocco. The conference provides a platform Both to celebrate these initiatives and to indicate strategic priorities, new and promising technologies and common goals of the countries that are partners in the Abraham Agreements."

The conference management includes Ruthi Alon, founder and CEO of Medstrada, Dr. Ora Der, a senior expert in medical sciences and medical innovation, and Dr. Nissim Darvish, a physician and CEO of Eliraz Ventures. The three attach great importance to hosting this distinguished delegation of the Partnership for Abraham Agreements for the purpose of promoting regional cooperation in the field of life sciences in the region, in the hope that this year's visit will inaugurate an annual tradition.

Dr. Nissim Darvish, physician and CEO of the Eliraz Ventures Foundation and a member of the conference board: "Through partnerships and innovation, the partners of the Abraham Accords can realize the potential to change the world of health and provide improved solutions for patients in the Middle East and beyond."

From left to right – Ruth Alon, Dr. Ora Dar, and Dr. Nissim Darvish (Photo: Alexander Allman)

Ruti Alon, member of the conference management: "Biomed Israel, which will host delegations from the Middle East, Africa and around the world, promotes the common vision of a healthier and happier society in Israel, among its neighbors and throughout the world. Medicine at its best can unite us all and realize the concept that all human beings have a right equal to health and well-being. Time and time again we have witnessed the ability of medical innovation to improve the quality of life and bridge cultures and countries."